ERBB2 and neoplasm: In addition, HER2 transgenic mice that spontaneously develop aggressive HER2 mammary carcinomas were tumor free until one year of age after HER2-VLP vaccination, with high levels of anti-HER2 antibodies lasting for up to six months after vaccination [16].